Liran Oren, Ph.D., (left) is shown with Ephraim Gutmark, Ph.D., and Ann Romaker, MD, and the VortexPAP device. Nearly 40 million Americans have obstructive sleep apnea, according to the Council on ...

People with both type 2 diabetes (T2D) and obstructive sleep apnea have a higher risk of death, but treatment with continuous ...

Earlier this week, the U.S. Department of Justice, representing the Food and Drug Administration and healthcare technology company Philips came to an agreement to no longer sell their sleep therapy or ...

ATLANTA, GA—Patients with obstructive sleep apnea (OSA) who have hypertension and are at high cardiovascular risk can obtain blood-pressure reductions similar to those seen with continuous positive ...